Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR III)

This study has been completed.
National Institute of Neurological Disorders and Stroke (NINDS)
Genentech, Inc.
Emissary International LLC
Information provided by (Responsible Party):
Daniel Hanley, Johns Hopkins University Identifier:
First received: October 31, 2008
Last updated: April 12, 2016
Last verified: April 2016